OBJECTIVE:Stroke risk due to intracranial atherosclerosis increases with degree of arterial stenosis. We evaluated the previously unexplored role of collaterals in modifying stroke risk in intracranial atherosclerosis and impact on subsequent stroke characteristics. METHODS:Collateral flow was graded in blind fashion on 287 of 569 baseline angiograms (stenoses of 50-99% and adequate collateral views) in the Warfarin--Aspirin Symptomatic Intracranial Disease (WASID) trial. Statistical models predicted stroke in the symptomatic arterial territory based on collateral flow grade, percentage of stenosis, and previously demonstrated independent covariates. RESULTS: Across all stenoses, extent of collaterals was a predictor for subsequent stroke in the symptomatic arterial territory (hazard ratio [HR] none vs good, 1.14; 95% confidence interval [CI], 0.39-3.30; poor vs good, 4.36; 95% CI, 1.46-13.07; p < 0.0001). For 70 to 99% stenoses, more extensive collaterals diminished risk of subsequent territorial stroke (HR none vs good, 4.60; 95% CI, 1.03-20.56; poor vs good, 5.90; 95% CI, 1.25-27.81; p = 0.0427). At milder degrees of stenoses (50-69%), presence of collaterals was associated with greater likelihood of subsequent stroke (HR none vs good, 0.18; 95% CI, 0.04-0.82; poor vs good, 1.78; 95% CI, 0.37-8.57; p < 0.0001). In multivariate analyses, extent of collaterals was an independent predictor for subsequent stroke in the symptomatic arterial territory (HR none vs good, 1.62; 95% CI, 0.52-5.11; poor vs good, 4.78; 95% CI, 1.55-14.7; p = 0.0019). INTERPRETATION: Collateral circulation is a potent determinant of stroke risk in intracranial atherosclerosis, demonstrating a protective role with severe stenoses and identifying more unstable milder stenoses.
RCT Entities:
OBJECTIVE:Stroke risk due to intracranial atherosclerosis increases with degree of arterial stenosis. We evaluated the previously unexplored role of collaterals in modifying stroke risk in intracranial atherosclerosis and impact on subsequent stroke characteristics. METHODS: Collateral flow was graded in blind fashion on 287 of 569 baseline angiograms (stenoses of 50-99% and adequate collateral views) in the Warfarin--Aspirin Symptomatic Intracranial Disease (WASID) trial. Statistical models predicted stroke in the symptomatic arterial territory based on collateral flow grade, percentage of stenosis, and previously demonstrated independent covariates. RESULTS: Across all stenoses, extent of collaterals was a predictor for subsequent stroke in the symptomatic arterial territory (hazard ratio [HR] none vs good, 1.14; 95% confidence interval [CI], 0.39-3.30; poor vs good, 4.36; 95% CI, 1.46-13.07; p < 0.0001). For 70 to 99% stenoses, more extensive collaterals diminished risk of subsequent territorial stroke (HR none vs good, 4.60; 95% CI, 1.03-20.56; poor vs good, 5.90; 95% CI, 1.25-27.81; p = 0.0427). At milder degrees of stenoses (50-69%), presence of collaterals was associated with greater likelihood of subsequent stroke (HR none vs good, 0.18; 95% CI, 0.04-0.82; poor vs good, 1.78; 95% CI, 0.37-8.57; p < 0.0001). In multivariate analyses, extent of collaterals was an independent predictor for subsequent stroke in the symptomatic arterial territory (HR none vs good, 1.62; 95% CI, 0.52-5.11; poor vs good, 4.78; 95% CI, 1.55-14.7; p = 0.0019). INTERPRETATION: Collateral circulation is a potent determinant of stroke risk in intracranial atherosclerosis, demonstrating a protective role with severe stenoses and identifying more unstable milder stenoses.
Authors: M I Chimowitz; J Kokkinos; J Strong; M B Brown; S R Levine; S Silliman; M S Pessin; E Weichel; C A Sila; A J Furlan Journal: Neurology Date: 1995-08 Impact factor: 9.910
Authors: Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks Journal: Stroke Date: 2003-07-17 Impact factor: 7.914
Authors: Heidi C Roberts; William P Dillon; Anthony J Furlan; Lawrence R Wechsler; Howard A Rowley; Nancy J Fischbein; Randall T Higashida; Carlos Kase; Gregory A Schulz; Ying Lu; Carolyn M Firszt Journal: Stroke Date: 2002-06 Impact factor: 7.914
Authors: Hao Jiang; Juan F Toscano; Michael Schiraldi; Shlee S Song; Konrad H Schlick; Oana M Dumitrascu; Raymond Liou; Patrick D Lyden; Jianwei Pan; Renya Zhan; Jeffrey L Saver; Nestor R Gonzalez Journal: J Stroke Cerebrovasc Dis Date: 2018-11-02 Impact factor: 2.136
Authors: Xinyi Leng; Lawrence K S Wong; Yannie Soo; Thomas Leung; Xinying Zou; Yongjun Wang; Edward Feldmann; Liping Liu; David Liebeskind Journal: Int J Stroke Date: 2013-10 Impact factor: 5.266
Authors: Daniel F Arteaga; Megan K Strother; Carlos C Faraco; L Taylor Davis; Allison O Scott; Manus J Donahue Journal: J Magn Reson Imaging Date: 2019-04-02 Impact factor: 4.813
Authors: Nestor R Gonzalez; David S Liebeskind; Joshua R Dusick; Fernando Mayor; Jeffrey Saver Journal: Neurosurg Rev Date: 2012-10-25 Impact factor: 3.042
Authors: Linfang Lan; Xinyi Leng; Vincent Ip; Yannie Soo; Jill Abrigo; Haipeng Liu; Florence Fan; Sze Ho Ma; Karen Ma; Bonaventure Ym Ip; Ka Lung Chan; Vincent Ct Mok; David S Liebeskind; Ka Sing Wong; Thomas W Leung Journal: J Cereb Blood Flow Metab Date: 2018-10-23 Impact factor: 6.200
Authors: Manus J Donahue; Lindsey M Dethrage; Carlos C Faraco; Lori C Jordan; Paul Clemmons; Robert Singer; J Mocco; Yu Shyr; Aditi Desai; Anne O'Duffy; Derek Riebau; Lisa Hermann; John Connors; Howard Kirshner; Megan K Strother Journal: Stroke Date: 2014-06-17 Impact factor: 7.914